Elsevier Inc.

SHERPA: Unknown

People

  1. Zelenetz
    Zelenetz
  2. Devlin
    Devlin
  3. Giralt
    Giralt
  4. Horwitz
    Horwitz
  5. Noy
    Noy
  6. Perales
    Perales
  7. Carter
    Carter
  8. Castro-Malaspina
    Castro-Malaspina
  9. Dahi
    Dahi
  10. Goldfarb
    Goldfarb

Groups

  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Survivorship Research (4)
  6. Epidemiology and Biostatistics (3)
  7. Executive Committee, Center for Hematologic Malignancies (3)
  8. Population Sciences Research Program (3)
  9. Biostatistics Service (2)
  10. Bone Marrow Transplant (2)
Search Within
  1. "Lymphoma"
  2. "2014"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Survivorship Research (4)
  6. Epidemiology and Biostatistics (3)

More Groups

People
  1. Andrew Zelenetz (4)
  2. Anas Younes (3)
  3. Craig Moskowitz (3)
  4. Jocelyn Migliacci (3)
  5. Ariela Noy (2)
  6. Craig Sauter (2)

More People

Years
  1. 2014 (8)
Publications
  1. Biology of Blood and Marrow Transplantation (3)
  2. Clinical Lymphoma, Myeloma and Leukemia (2)
  3. Hematology/Oncology Clinics of North America (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. Journal of Sexual Medicine (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pegfilgrastim for patients with newly diagnosed diffuse large B-cell lymphoma undergoing dose adjusted EPOCH-R: The MSKCC experience
    Meeting Abstract

    Lunning, M. A.; Maragulia, J.; Horwitz, S. M.; Moskowitz, C. H.; Noy, A.; Zelenetz, A. D.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience
    Meeting Abstract

    Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Improvements in treatments for Hodgkin lymphoma over a 50-year period lead to fewer second malignancies
    Meeting Abstract

    Dabaja, B.; Shihadeh, F.; Rodriguez, M.; Etzel, C.; Liang, F.; Shirvani, S. M.; Ballas, L. K.; Allen, P.; Fanale, M.; Wogan, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S.; Jackson, T.; Carter, J.; Dickler, M.; Noy, A.
    Journal of Sexual Medicine (2014)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in the brentuximab vedotin era
    Meeting Abstract

    Anderlini, P.; Saliba, R.; Ledesma, C.; Chancoco, C. M.; Alexander, T. R.; Alousi, A. M.; Hosing, C.; Khouri, I. F.; Nieto, Y.; Popat, U. R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin for the treatment of patients with hodgkin lymphoma
    Journal Article

    Younes, A.
    Hematology/Oncology Clinics of North America (2014)

    Fulltext@MSK | Save